Black Rock Inc. Zomedica Corp. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Zomedica Corp. stock. As of the latest transaction made, Black Rock Inc. holds 9,862,981 shares of ZOM stock, worth $591,778. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,862,981

Previous 9,862,981 -0.0%

Holding current value

$591,778

Previous $1.48 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.12 - $0.19 $63,320 - $100,257	-527,669 Reduced 5.08%	9,862,981 $1.48 Million
Q3 2023 Nov 13, 2023	SELL	$0.16 - $0.23 $179,259 - $257,686	-1,120,374 Reduced 9.73%	10,390,650 $1.77 Million
Q2 2023 Aug 11, 2023	BUY	$0.19 - $0.22 $240,194 - $278,120	1,264,183 Added 12.34%	11,511,024 $2.3 Million
Q1 2023 May 12, 2023	SELL	$0.16 - $0.29 $168,455 - $305,326	-1,052,849 Reduced 9.32%	10,246,841 $2.15 Million
Q4 2022 Feb 13, 2023	SELL	$0.16 - $0.25 $3,374 - $5,272	-21,090 Reduced 0.19%	11,299,690 $1.81 Million
Q3 2022 Nov 14, 2022	SELL	$0.2 - $0.38 $6,543 - $12,432	-32,718 Reduced 0.29%	11,320,780 $2.39 Million
Q2 2022 Aug 12, 2022	SELL	$0.2 - $0.34 $412,960 - $702,032	-2,064,801 Reduced 15.39%	11,353,498 $2.5 Million
Q1 2022 May 12, 2022	BUY	$0.28 - $0.4 $198,238 - $283,197	707,993 Added 5.57%	13,418,299 $4.52 Million
Q4 2021 Feb 10, 2022	SELL	$0.31 - $0.58 $1.68 Million - $3.13 Million	-5,403,693 Reduced 29.83%	12,710,306 $3.9 Million
Q3 2021 Nov 09, 2021	BUY	$0.46 - $0.81 $362,762 - $638,778	788,615 Added 4.55%	18,113,999 $9.48 Million
Q2 2021 Aug 11, 2021	BUY	$0.72 - $1.46 $12.5 Million - $25.3 Million	17,325,384 New	17,325,384 $14.4 Million

Others Institutions Holding ZOM

# of Institutions

Shares Held

16.3M

Call Options Held

Put Options Held

View Full List

About Zomedica Corp.

Ticker ZOM
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 979,950,016
Market Cap $58.8M
Description
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...

More about ZOM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account